These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 9321522

  • 1. Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.
    Sauer JM, Bao J, Smith RL, Kuester RK, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Oct; 25(10):1184-90. PubMed ID: 9321522
    [Abstract] [Full Text] [Related]

  • 2. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M, Sipes IG.
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [Abstract] [Full Text] [Related]

  • 3. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [Abstract] [Full Text] [Related]

  • 4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 6. Lauramide diethanolamine absorption, metabolism, and disposition in rats and mice after oral, intravenous, and dermal administration.
    Mathews JM, deCosta K, Thomas BF.
    Drug Metab Dispos; 1996 Jul; 24(7):702-10. PubMed ID: 8818565
    [Abstract] [Full Text] [Related]

  • 7. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J.
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [Abstract] [Full Text] [Related]

  • 8. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S, Shah B, Zhang J, Zeng Z, Kirkesseli S, Jensen BK.
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 12. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S, Shyu WC, Shukla UA, Dandekar KA, Barbhaiya RH.
    Drug Metab Dispos; 1993 Oct; 21(3):447-53. PubMed ID: 8100500
    [Abstract] [Full Text] [Related]

  • 13. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB, National Toxicology Program.
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [Abstract] [Full Text] [Related]

  • 14. Disposition and metabolism of finasteride in dogs.
    Carlin JR, Christofalo P, Arison BH, Ellsworth RE, Rosegay A, Miller RR, Chiu SH, VandenHeuvel WJ.
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [Abstract] [Full Text] [Related]

  • 15. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [Abstract] [Full Text] [Related]

  • 16. Disposition and metabolism of carbovir in mice dosed intravenously or orally.
    el Dareer SM, Tillery KF, Rose LM, Struck RF, Hill DL.
    Drug Metab Dispos; 1990 Jul; 18(6):842-5. PubMed ID: 1981526
    [Abstract] [Full Text] [Related]

  • 17. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 18. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH.
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA, Clark AJ, McClymont EL, Staley JL.
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [Abstract] [Full Text] [Related]

  • 20. Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat.
    Fasano WJ, Carpenter SC, Gannon SA, Snow TA, Stadler JC, Kennedy GL, Buck RC, Korzeniowski SH, Hinderliter PM, Kemper RA.
    Toxicol Sci; 2006 Jun; 91(2):341-55. PubMed ID: 16543293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.